ArticleAntimicrobial agents and chemotherapy2012

Preclinical characterization of JTK-853, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.

Izuru Ando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.